Jiaxi Wu

975 total citations
13 papers, 822 citations indexed

About

Jiaxi Wu is a scholar working on Molecular Biology, Oncology and Toxicology. According to data from OpenAlex, Jiaxi Wu has authored 13 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Toxicology. Recurrent topics in Jiaxi Wu's work include Cancer therapeutics and mechanisms (8 papers), DNA Repair Mechanisms (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Jiaxi Wu is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), DNA Repair Mechanisms (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Jiaxi Wu collaborates with scholars based in United States and China. Jiaxi Wu's co-authors include Leroy F. Liu, Pu Duann, Peter D’Arpa, Philippe Pourquier, Yves Pommier, Gary S. Laco, Yoshimasa Urasaki, Youcef M. Rustum, Károly Tóth and Tsai‐Kun Li and has published in prestigious journals such as Nucleic Acids Research, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

Jiaxi Wu

12 papers receiving 798 citations

Peers

Jiaxi Wu

MB

ONCOL

TOXIC

OC

PHARM

Karin C. Nitiss United States

Seojeong Park South Korea

T Yokokura Japan

Sai-Peng Sim Malaysia

M K Ritke United States

Kyungbo Kim United States

Harry A. Rogoff United States

Jean‐François Gaussin Belgium

Alessia Lopergolo Italy

Eiji Kumazawa Japan

Karin C. Nitiss United States

Jiaxi Wu

936 ×1.3

MB

425 ×1.2

ONCOL

93 ×0.7

TOXIC

84 ×1.1

OC

57 ×0.9

PHARM

Citations per year, relative to Jiaxi Wu Jiaxi Wu (= 1×) peers Karin C. Nitiss

Countries citing papers authored by Jiaxi Wu

Since Specialization

Citations

This map shows the geographic impact of Jiaxi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaxi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaxi Wu more than expected).

Fields of papers citing papers by Jiaxi Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaxi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaxi Wu. The network helps show where Jiaxi Wu may publish in the future.

Co-authorship network of co-authors of Jiaxi Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaxi Wu. A scholar is included among the top collaborators of Jiaxi Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaxi Wu. Jiaxi Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Li, Jiawei, Chunhui Huang, Zhaoming Liu, et al.. (2025). RNA-Targeting CRISPR/CasRx system relieves disease symptoms in Huntington’s disease models. Molecular Neurodegeneration. 20(1). 4–4. 6 indexed citations

2.

Zhang, Li, et al.. (2024). Fine-Scale Genetic Structure of Curculio chinensis (Coleoptera: Curculionidae) Based on Mitochondrial COI: The Role of Host Specificity and Spatial Distance. Insects. 15(2). 116–116.

3.

Wu, Jiaxi & Liwei Zhang. (2024). Research on the Topology of 750V Push-Pull DC/DC Converters for Railway Trains. 355–360. 1 indexed citations

4.

Huang, Chunhui, et al.. (2024). Abnormal outer and inner retina in a mouse model of Huntington’s disease with age. Frontiers in Aging Neuroscience. 16. 1434551–1434551. 1 indexed citations

5.

Chen, Fuxue, et al.. (2016). Low-Fidelity Alternative Dna Repair Carcinogenesis Theory May Interpret Many Cancer Features and Anticancer Strategies. Future Oncology. 12(16). 1897–1910. 1 indexed citations

6.

Wu, Jiaxi, et al.. (2002). Chk1 signaling pathways that mediated G2M checkpoint in relation to the cellular resistance to the novel topoisomerase I poison BNP1350. Biochemical and Biophysical Research Communications. 295(2). 435–444. 16 indexed citations

7.

Wu, Jiaxi, et al.. (2002). Induction of Biphasic DNA Double Strand Breaks and Activation of Multiple Repair Protein Complexes by DNA Topoisomerase I Drug 7-Ethyl-10-hydroxy-camptothecin. Molecular Pharmacology. 61(4). 742–748. 41 indexed citations

8.

Wu, Jiaxi, et al.. (2002). Induction of Biphasic DNA Double Strand Breaks and Activation of Multiple Repair Protein Complexes by DNA Topoisomerase I Drug 7-Ethyl-10-hydroxy-camptothecin. Molecular Pharmacology. 61(4). 742–748. 3 indexed citations

9.

Wu, Jiaxi, et al.. (2002). Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38. International Journal of Oncology. 21(5). 1059–66. 5 indexed citations

10.

Desai, Shyamal D., et al.. (2000). Ubiquitin, SUMO‐1, and UCRP in Camptothecin Sensitivity and Resistance. Annals of the New York Academy of Sciences. 922(1). 306–308. 20 indexed citations

11.

Pommier, Yves, Philippe Pourquier, Yoshimasa Urasaki, Jiaxi Wu, & Gary S. Laco. (1999). Topoisomerase I inhibitors: selectivity and cellular resistance. Drug Resistance Updates. 2(5). 307–318. 152 indexed citations

12.

Wu, Jiaxi & Leroy F. Liu. (1997). Processing of topoisomerase I cleavable complexes into DNA damage by transcription. Nucleic Acids Research. 25(21). 4181–4186. 129 indexed citations

13.

Liu, Leroy F., et al.. (1996). Mechanism of Action of Camptothecin. Annals of the New York Academy of Sciences. 803(1). 44–49. 447 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact